Cytokinetics CYTK Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Prepaid Expense and Other Assets at other companies
Other financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Cytokinetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytokinetics's increase (decrease) in prepaid expense and other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytokinetics's increase (decrease) in prepaid expense and other assets?
- Cytokinetics (CYTK) reported increase (decrease) in prepaid expense and other assets of -$2.06M in Q1 2026.
- How has Cytokinetics's increase (decrease) in prepaid expense and other assets changed year-over-year?
- Cytokinetics's increase (decrease) in prepaid expense and other assets decreased by 647.1% year-over-year, from $376K to -$2.06M.
- What is the long-term trend for Cytokinetics's increase (decrease) in prepaid expense and other assets?
- Over 2 years (2023 to 2025), Cytokinetics's increase (decrease) in prepaid expense and other assets has grown at a 35.6% compound annual growth rate (CAGR), from -$1.6M to $2.93M.